= Abstract = Patent ductus arteriosus (PDA) is a common congenital heart defect. All PDAs, regardless of size or degree of symptoms, require occlusion. Transcatheter PDA occlusion features fewer complications than trans-thoracic closure. It is also more cost-effective and has an excellent occlusion rate. Therefore, transcatheter PDA occlusion is accepted as the standard treatment option for PDA. However, tubular-type PDAs are difficult to close with ordinary detachable coils or the Amplatzer Duct Occluder; thus, these lesions remain a challenge for transcatheter closure. We attempted to occlude a tubular-type PDA by using an oversized Amplatzer Vascular Plug, which allowed intraluminal packing of the ductus. By using this treatment method, PDA occlusion was achieved safely with an excellent final outcome. We suggest that this approach may be a good option for transcatheter closure of a tubular-type PDA. (Korean J Pediatr 2009;52:1035-1037 
Introduction
Since the first catheter-based closure of a patent ductus arteriosus (PDA) reported by Porstmann et al. 1) . However, the tubular-type PDAs still remain a challenge to transcatheter treatment. In this report, we describe successful closure of a tubular PDA using an Amplatzer Vascular Plug (AVP; AGA medical Golden Valley, MN, USA).
Case report
A 3-year-old boy was transferred to our institute for treatment of his known congenital heart defect. He diagnosed as ventricular septal defect (VSD) and PDA at his birth during the evaluation of cardiac murmur. He had no symptoms, but his parents wanted the opinion of our institute. Echocardiography showed a small perimem---branous VSD and a small PDA. The size of VSD was about 2.5 mm and there was no evidence of aortic regurgitation.
A thoracic roentgenogram showed no definite cardiomegaly or increased pulmonary vascularity. We decided to close his PDA first, and a cardiac catheterization was performed.
Angiography revealed a long tubular PDA (Krichenko 
Discussion
PDA is one of the most common congenital cardiac defect 4, 5) . There is no controversy about recommending closure of all PDAs, regardless of their size or severity 5) . Small PDAs, lessor than 2 mm, are generally closed with detachable embolization coils. Detachable coils have many advantages in such that they can be placed by using a smaller sheath, they are easy to reposition and they have a low rate of complication as well as a low cost 6, 7) . On the other hand, an ADO is a preferable device for larger PDAs more than 4 mm in size. The ADO comes in various sizes and it has an excellent occlusion rate 8, 9) . Unfortunately, there are wide variety of size and shapes of PDA, so no one device is optimal or applicable for all PDAs. The tubular-tye PDAs, especially, are still a challenging entity for the interventional cardiologist. In these cases, ADO is not suitable and the use of coils bears a high risk of complications such as residual leakage or embolization of the coil. In spite of the use of AVPs on a large scale [10] [11] [12] , some reports have claimed that the use of an AVP is contraindicated for the large tubular-type of PDA 13) . In this case, we tried using a larger size of AVP than is generally recommended and that brought about packing of the PDA.
An AVP is a self-expanding, cylindrical device that is made out of nitinol wire mesh and unlike other Amplatzer occlusion devices, it has no occlusive fabric. Therefore it has previously been considered unsuitable for embolization of high flow lesions such as PDA. According to our experience with the tubular-type PDA, especially those with a narrow pulmonic end, AVPs may be a reasonable option in carefully-selected cases. 
